Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 407,992 |
|
|||||
| News | - | ||||||
| Day High | 28.27 | Low High |
|||||
| Day Low | 27.81 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Royalty Pharma PLC | RPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.07 | 0.25% | 28.18 | 14:06:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.00 | 27.81 | 28.27 | 28.11 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,503 | 407,992 | $ 28.13 | $ 11,476,453 | - | 25.92 - 35.76 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:06:48 | 42 | $ 28.185 | USD |
Royalty Pharma PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.82B | 597.43M | - | 2.35B | 1.13B | 1.90 | 14.82 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Royalty Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.85 | 28.40 | 27.21 | 27.95 | 3,013,047 | 0.33 | 1.18% |
| 1 Month | 30.52 | 30.55 | 27.21 | 28.52 | 2,679,731 | -2.34 | -7.67% |
| 3 Months | 28.45 | 31.655 | 27.21 | 29.57 | 2,889,276 | -0.27 | -0.95% |
| 6 Months | 27.19 | 31.655 | 26.07 | 28.74 | 2,600,249 | 0.99 | 3.64% |
| 1 Year | 35.47 | 35.76 | 25.92 | 29.60 | 2,441,971 | -7.29 | -20.55% |
| 3 Years | 44.00 | 47.10 | 25.92 | 36.10 | 2,119,246 | -15.82 | -35.95% |
| 5 Years | 45.90 | 57.50 | 25.92 | 38.24 | 2,140,765 | -17.72 | -38.61% |
Royalty Pharma Description
| Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. |
